Multippel Sklerose

Vitenskapelig artikkel

• Gavasso, Sonia; Haugsøen, Jonas Bull; Kleftogiannis, Dimitrios et al. (2025). High-dimensional Immune Profiling Following Autologous Hematopoietic Stem Cell Transplantation in Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• Serkland, Trond Trætteberg; Skrede, Silje; Hallin, Erik Ingmar et al. (2025). Pharmacokinetic-pharmacodynamic modelling in a clinical pilot study of rituximab in multiple sclerosis: Towards personalized dosing interval. (ekstern lenke)
• Rød, Brit Ellen; Høgestøl, Einar August; Torkildsen, Øivind et al. (2025). Comparative effectiveness of rituximab and cladribine in relapsing–remitting multiple sclerosis: A target trial emulation. (ekstern lenke)
• Fossum, Maria Therese; Torgauten, Hilde Marie; Aarseth, Jan Harald et al. (2025). Early extended interval dosing of rituximab in multiple sclerosis: A comparative cohort study on efficacy and safety. (ekstern lenke)
• Eid, Karine; Torkildsen, Øivind; Aarseth, Jan Harald et al. (2024). Migraine in the multiple sclerosis prodrome: a prospective nationwide cohort study in pregnant women. (ekstern lenke)
• Torgauten, Hilde Marie; Onyango, Therese Bredholt; Ljostveit, Sonja et al. (2024). Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients. (ekstern lenke)
• Coerver, E.; Schoof, L.; Hogenboom, L. et al. (2024). The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis. (ekstern lenke)
• Lereim, Ragnhild Reehorst; Nytrova, Petra; Guldbrandsen, Astrid et al. (2024). Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis. (ekstern lenke)
• Riemer, Frank; Skorve, Ellen; Pasternak, Ofer et al. (2023). Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis. (ekstern lenke)
• Bhan, Alok; Jacobsen, Cecilie; Dalen, Ingvild et al. (2023). Neurofilament and Brain Atrophy and Their Association with Cognition in Multiple Sclerosis: A 10-Year Follow-Up Study. (ekstern lenke)
• Førde, Jan-Lukas; Herfindal, Lars; Myhr, Kjell-Morten et al. (2023). Ocrelizumab and ofatumumab, but not rituximab, trigger complement induction in vitro. (ekstern lenke)
• Habbestad, Andrea Kyvik; Willumsen, Johannes Sverre; Aarseth, Jan Harald et al. (2023). Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study. (ekstern lenke)
• Rød, Brit Ellen; Wergeland, Stig; Bjørnevik, Kjetil Lauvland et al. (2023). Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy. (ekstern lenke)
• Kapali, Akash; Daltveit, Anne Kjersti Nesje; Myhr, Kjell-Morten et al. (2023). Childbirth delivery mode and the risk of multiple sclerosis: A prospective population-based study. (ekstern lenke)
• Karlowicz, Jakob Rishovd; Klakegg, Mattias; Aarseth, Jan Harald et al. (2023). Predictors of hospitalization due to infection in rituximab-treated MS patients. (ekstern lenke)
• Eid, Karine; Torkildsen, Øivind; Aarseth, Jan Harald et al. (2022). Association of adverse childhood experiences with the development of multiple sclerosis. (ekstern lenke)
• Eid, Karine; Torkildsen, Øivind; Aarseth, Jan Harald et al. (2022). Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy. (ekstern lenke)
• Lie, Ingrid Anne; Kerklingh, Emma; Wesnes, Kristin et al. (2022). The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis. (ekstern lenke)
• Grytten, Nina; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen et al. (2022). Cancer related mortality in multiple sclerosis. A population based cohort study. (ekstern lenke)
• Skorve, Ellen; Lundervold, Astri J.; Torkildsen, Øivind et al. (2022). Brief international cognitive assessment for MS (BICAMS) and global brain volumes in early stages of MS – A longitudinal correlation study. (ekstern lenke)
• Hallin, Erik Ingmar; Serkland, Trond Trætteberg; Myhr, Kjell-Morten et al. (2022). Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry. (ekstern lenke)
• Rød, Brit Ellen; Torkildsen, Øivind; Myhr, Kjell-Morten et al. (2022). Safety of breast feeding during rituximab treatment in multiple sclerosis. (ekstern lenke)
• Willumsen, Johannes Sverre; Grytten, Nina; Aarseth, Jan Harald et al. (2022). Mortality and cause of death in multiple sclerosis in western Norway 1950-2021: A registry-based linkage study. (ekstern lenke)
• Lie, Ingrid Anne; Wesnes, Kristin; Kvistad, Silje Agnethe Stokke et al. (2022). The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• Nakken, Ola; Holmøy, Trygve; Stigum, Hein et al. (2022). Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study. (ekstern lenke)
• Lie, Ingrid Anne; Kacar, Sezgi; Wesnes, Kristin et al. (2022). Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study. (ekstern lenke)
• Grytten, Nina; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen et al. (2021). Incidence of cancer in multiple sclerosis before and after the treatment era– a registry- based cohort study. (ekstern lenke)
• Wesnes, Kristin; Myhr, Kjell-Morten; Riise, Trond et al. (2021). Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. (ekstern lenke)
• Eid, Karine; Torkildsen, Øivind Fredvik Grytten; Aarseth, Jan Harald et al. (2021). Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study. (ekstern lenke)
• Mosleth, Ellen Færgestad; Vedeler, Christian Alexander; Liland, Kristian Hovde et al. (2021). Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis. (ekstern lenke)
• Bhan, Alok; Jacobsen, Cecilie; Dalen, Ingvild et al. (2021). CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. (ekstern lenke)
• König, Marton; Lorentzen, Åslaug Rudjord; Torgauten, Hilde Marie et al. (2021). Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations. (ekstern lenke)
• Jacobsen, Cecilie; Zivadinov, Robert; Myhr, Kjell-Morten et al. (2021). Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study. (ekstern lenke)
• Torgauten, Hilde Marie; Myhr, Kjell-Morten; Wergeland, Stig et al. (2021). Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study. (ekstern lenke)
• Bringeland, Gerd Haga; Blaser, Nello; Myhr, Kjell-Morten et al. (2021). Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic. (ekstern lenke)
• Norborg, Hilde; Riise, Trond; Myhr, Kjell-Morten et al. (2021). Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis. (ekstern lenke)
• Oveland, Eystein; Ahmad, Intakhar; Lereim, Ragnhild Reehorst et al. (2021). Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis. (ekstern lenke)
• Benjaminsen, Espen; Myhr, Kjell-Morten; Torkildsen, Nina Agnethe Grytten et al. (2020). Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry. (ekstern lenke)
• Bringeland, Gerd Haga; Myhr, Kjell-Morten; Vedeler, Christian A. et al. (2020). Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study. (ekstern lenke)
• Myhr, Kjell-Morten; Torkildsen, Øivind Fredvik (2020). Serum NFL levels should be used to monitor multiple sclerosis evolution - No.. (ekstern lenke)
• Røsjø, Egil Rørvik; Lindstrøm, Jonas Christoffer; Holmøy, Trygve et al. (2020). Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Myhr, Kjell-Morten; Skogen, Vegard et al. (2020). Tenofovir as a treatment option for multiple sclerosis. (ekstern lenke)
• Jacobsen, Cecilie; Zivadinov, Robert; Myhr, Kjell-Morten et al. (2020). Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. (ekstern lenke)
• Hakkarainen, Katja Marja; Juuti, Rosa; Burkill, Sarah et al. (2020). Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden. (ekstern lenke)
• Bringeland, Gerd Haga; Blaser, Nello; Myhr, Kjell-Morten et al. (2020). Wearing-off at the end of natalizumab dosing intervals is associated with low receptor occupancy. (ekstern lenke)
• Willumsen, Johannes Sverre; Aarseth, Jan Harald; Myhr, Kjell-Morten et al. (2020). High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950–2018. (ekstern lenke)
• Skorve, Ellen; Lundervold, Astri; Torkildsen, Øivind et al. (2020). A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS. (ekstern lenke)
• Grytten, Nina; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen et al. (2019). Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study. (ekstern lenke)
• Benjaminsen, Espen; Myhr, Kjell-Morten; Grytten, Nina et al. (2019). Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry. (ekstern lenke)
• Skorve, Ellen; Lundervold, Astri; Torkildsen, Øivind et al. (2019). The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS). (ekstern lenke)
• Nystad, Agnes Elisabeth; Lereim, Ragnhild Reehorst; Wergeland, Stig et al. (2019). Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model. (ekstern lenke)
• Bringeland, Gerd Haga; Bader, Lucius; Blaser, Nello et al. (2019). Optimization of receptor occupancy assays in mass cytometry: Standardization across channels with QSC beads. (ekstern lenke)
• Burkill, Sarah; Vattulainen, Pia; Geissbuehler, Yvonne et al. (2019). The Association Between Exposure to Interferon-Beta During Pregnancy and Birth Measurements in Offspring of Women With Multiple Sclerosis. (ekstern lenke)
• Larsen, Christopher Storm; Myhr, Kjell-Morten; Farbu, Elisabeth et al. (2019). Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial. (ekstern lenke)
• Stokke, Silje Agnethe; Lehmann, Anne Kristine; Trovik, Linn et al. (2019). Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. (ekstern lenke)
• Bhan, Alok; Jacobsen, Cecilie; Myhr, Kjell-Morten et al. (2018). Neurofilaments and 10-year follow-up in multiple sclerosis. (ekstern lenke)
• Stokke, Silje Agnethe; Myhr, Kjell-Morten; Holmøy, Trygve et al. (2018). Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis. (ekstern lenke)
• Magalhaes, Sandra; Pugliatti, Maura; Riise, Trond et al. (2018). Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study. (ekstern lenke)
• Glaser, A.; Stahmann, A; Meissner, Tobias et al. (2018). Multiple sclerosis registries in Europe – An updated mapping survey. (ekstern lenke)
• Bjørnevik, Kjetil Lauvland; Myhr, Kjell-Morten; Beiske, Antonie Giæver et al. (2018). α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients.. (ekstern lenke)
• Olberg, Henning Kristian; Eide, Geir Egil; Cox, Rebecca Jane et al. (2018). Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. (ekstern lenke)
• Svendsen, Bjørn; Grytten, Nina; Bø, Lars et al. (2018). The economic impact of multiple sclerosis to the patients and their families in Norway. (ekstern lenke)
• Mitrovic, Mitja; Patsopoulos, Nikolaos A.; Beecham, Ashley H. et al. (2018). Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. (ekstern lenke)
• Bjørnevik, Kjetil; Riise, Trond; Benjaminsen, Espen et al. (2017). Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study. (ekstern lenke)
• Kroksveen, Ann Cathrine; Guldbrandsen, Astrid; Vaudel, Marc et al. (2017). In-depth cerebrospinal fluid quantitative proteome and deglycoproteome analysis: presenting a comprehensive picture of pathways and processes affected by multiple sclerosis. (ekstern lenke)
• Olafsson, Sigurgeir; Olafsson, S.; Stridh, Pernilla et al. (2017). Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations. (ekstern lenke)
• Cortese, Marianna; Riise, Trond; Bjørnevik, Kjetil Lauvland et al. (2017). Body size and physical exercise, and the risk of multiple sclerosis. (ekstern lenke)
• Varhaug, Kristin Nielsen; Barro, Christian; Bjørnevik, Kjetil Lauvland et al. (2017). Neurofilament light chain predicts disease activity in relapsing-remitting MS. (ekstern lenke)
• Wesnes, Kristin; Myhr, Kjell-Morten; Riise, Trond et al. (2017). Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study. (ekstern lenke)
• Oveland, Eystein; Nystad, Agnes Elisabeth; Berven, Frode et al. (2017). 1,25-Dihydroxyvitamin-D3 induces brain proteomic changes in cuprizone mice during remyelination involving calcium proteins. (ekstern lenke)
• Lunde, Hanne Marie; Assmus, Jörg; Myhr, Kjell-Morten et al. (2017). Survival and cause of death in multiple sclerosis: A 60-year longitudinal population study. (ekstern lenke)
• Benjaminsen, Espen; Myhr, Kjell-Morten; Alstadhaug, Karl Bjørnar (2017). The prevalence and characteristics of epilepsy in patients with multiple sclerosis in Nordland county, Norway. (ekstern lenke)
• Holmøy, Trygve; Torkildsen, Øivind; Myhr, Kjell-Morten (2017). An update on cladribine for relapsing-remitting multiple sclerosis. (ekstern lenke)
• Lereim, Ragnhild Reehorst; Oveland, Eystein; Xiao, Y. et al. (2016). The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis. (ekstern lenke)
• Guldbrandsen, Astrid; Farag, Yehia Mohamed Mokhtar; Kroksveen, Ann Cathrine et al. (2016). CSF-PR 2.0: an interactive literature guide to quantitative cerebrospinal fluid mass spectrometry data from neurodegenerative disorders. (ekstern lenke)
• Grytten, Nina; Skår, Anne Britt; Aarseth, Jan Harald et al. (2016). The influence of coping styles on long-term employment in multiple sclerosis: A prospective study. (ekstern lenke)
• Holmøy, Trygve; Esbensen, Qin Ying; Torkildsen, Øivind et al. (2016). WT1 and interferon-β–vitamin D association in MS: a longitudinal study.. (ekstern lenke)
• Varhaug, Kristin; Vedeler, Christian A.; Myhr, Kjell-Morten et al. (2016). Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis. (ekstern lenke)
• Kappos, Ludwig; Edan, Gilles; Freedman, Mark S. et al. (2016). The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. (ekstern lenke)
• Disanto, Giulio; Adiutori, R; Martinelli, V et al. (2016). Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. (ekstern lenke)
• Berger, Thomas; Elovaara, Irina; Fredrikson, Sten et al. (2016). Alemtuzumab use in clinical practice: recommendations from European multiple sclerosis experts. (ekstern lenke)
• Opsahl, Jill Anette; Vaudel, Marc; Guldbrandsen, Astrid et al. (2016). Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. (ekstern lenke)
• Grytten, Nina; Aarseth, Jan Harald; Lunde, Hanne Marie et al. (2016). A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway. (ekstern lenke)
• Torkildsen, Øivind; Myhr, Kjell-Morten; Bø, Lars (2016). Disease-modifying treatments for multiple sclerosis – a review of approved medications. (ekstern lenke)
• Kvistad, Silje; Myhr, Kjell-Morten; Holmøy, Trygve et al. (2016). No association of tobacco use and disease activity in multiple sclerosis. (ekstern lenke)
• Bjørnevik, Kjetil Lauvland; Riise, Trond; Bostrom, Inger et al. (2016). Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study. (ekstern lenke)
• Wergeland, Stig; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv et al. (2016). Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients. (ekstern lenke)
• Cortese, Marianna; Riise, Trond; Bjørnevik, Kjetil Lauvland et al. (2016). Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom. (ekstern lenke)
• Goulden, R; Riise, Trond; Myhr, Kjell-Morten et al. (2016). Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study. (ekstern lenke)
• Keshari, Pankaj; Harbo, Hanne Flinstad; Myhr, Kjell-Morten et al. (2016). Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood. (ekstern lenke)
• Cortese, Marianna; Riise, Trond; Bjørnevik, Kjetil Lauvland et al. (2015). Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.. (ekstern lenke)
• Bjørnevik, Kjetil Lauvland; Riise, Trond; Cortese, Marianna et al. (2015). Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study. (ekstern lenke)
• Kroksveen, Ann Cathrine; Opsahl, Jill Anette; Guldbrandsen, Astrid et al. (2015). Cerebrospinal fluid proteomics in multiple sclerosis. (ekstern lenke)
• Stokke, Silje Agnethe; Myhr, Kjell-Morten; Holmøy, Trygve et al. (2015). Body mass index influence interferon-beta treatment response in multiple sclerosis. (ekstern lenke)
• Røsjø, Egil Rørvik; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv et al. (2015). Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. (ekstern lenke)
• Fjær, Sveinung; Bø, Lars; Myhr, Kjell-Morten et al. (2015). Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model. (ekstern lenke)
• Sundal, Christina Heidemann; Baker, Matt C.; Karrenbauer, Virginija Danylaité et al. (2015). Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. (ekstern lenke)
• Kroksveen, Ann Cathrine; Jaffe, Jacob D.; Aasebø, Elise et al. (2015). Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. (ekstern lenke)
• Alme, Maria Nordheim; Nystad, Agnes Elisabeth; Bø, Lars et al. (2015). Fingolimod does not enhance cerebellar remyelination in the cuprizone model. (ekstern lenke)
• Ragnedda, Giammario; Leoni, Stefania; Parpinel, Maria et al. (2015). Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. (ekstern lenke)
• Goris, An; Pauwels, Ine; Gustavsen, Marte Wendel et al. (2015). Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. (ekstern lenke)
• Magalhaes, Sandra; Pugliatti, Maura; Casetta, Ilaria et al. (2015). The EnvIMS study: Design and methodology of an international case-control study of environmental risk factors in multiple sclerosis. (ekstern lenke)
• Westerlind, Helga; Imrell, Kerstin; Ramanujam, Ryan et al. (2015). Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. (ekstern lenke)
• Wesnes, Kristin; Riise, Trond; Casetta, Ilaria et al. (2015). Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study. (ekstern lenke)
• Jacobsen, Cecilie Osman; Hagemeier, Jesper; Myhr, Kjell-Morten et al. (2014). Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study. (ekstern lenke)
• Gavasso, Sonia; Mosleth, Ellen Færgestad; Marøy, Tove Helene et al. (2014). Deficient phosphorylation of stat-1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-beta. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Aarseth, Jan Harald; Benjaminsen, Espen et al. (2014). Month of birth and risk of multiple sclerosis: confounding and adjustments. (ekstern lenke)
• Lunde, Hanne Marie; Telstad, Wenche; Grytten, Nina Agnethe et al. (2014). Employment among patients with multiple sclerosis-A population study. (ekstern lenke)
• Nystad, Agnes Elisabeth; Wergeland, Stig; Aksnes, Lage et al. (2014). Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model. (ekstern lenke)
• Torkildsen, Øivind; Myhr, Kjell-Morten; Wergeland, Stig (2014). Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS. (ekstern lenke)
• Aasebø, Elise; Opsahl, Jill Anette; Bjørlykke, Yngvild et al. (2014). Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome. (ekstern lenke)
• Guldbrandsen, Astrid; Vethe, Heidrun; Farag, Yehia Mohamed Mokhtar et al. (2014). In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR). (ekstern lenke)
• Klevan, Gry; Jacobsen, Cecilie Osman; Aarseth, Jan Harald et al. (2014). Health related quality of life in patients recently diagnosed with multiple sclerosis. (ekstern lenke)
• Olberg, Henning Kristian; Cox, Rebecca Jane; Nøstbakken, Jane Kristin et al. (2014). Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: An explorative study. (ekstern lenke)
• Gustavsen, Marte Wendel; Viken, Marte K; Celius, Elisabeth Gulowsen et al. (2014). Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general. (ekstern lenke)
• Lossius, Peter Andreas Vold; Riise, Trond; Pugliatti, Maura et al. (2014). Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study. (ekstern lenke)
• Røsjø, Egil Rørvik; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv et al. (2014). Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. (ekstern lenke)
• Bjørnevik, Kjetil Lauvland; Riise, Trond; Casetta, Ilaria et al. (2014). Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study. (ekstern lenke)
• Stokke, Silje Agnethe; Myhr, Kjell-Morten; Holmøy, Trygve et al. (2014). Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis. (ekstern lenke)
• Løken, Kristin Ingeleiv; Myhr, Kjell-Morten; Bakke, Jacob et al. (2013). Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. (ekstern lenke)
• Comi, Giancarlo; Martinelli, Vittorio; Rodegher, Mariaemma et al. (2013). Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. (ekstern lenke)
• Kroksveen, Ann Cathrine; Aasebø, Elise; Vethe, Heidrun et al. (2013). Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. (ekstern lenke)
• Leone, Maurizio A.; Barizzone, Nadia; Esposito, Federica et al. (2013). Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. (ekstern lenke)
• Mero, Inger-Lise; Gustavsen, Marte Wendel; Sæther, Hanne Skarpodde et al. (2013). Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. (ekstern lenke)
• Salzer, Jonatan; Myhr, Kjell-Morten (2013). Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No. (ekstern lenke)
• Torkildsen, Øivind; Løken-Amsrud, Kristin Ingeleiv; Wergeland, Stig et al. (2013). Fat-soluble vitamins as disease modulators in multiple sclerosis. (ekstern lenke)
• Baranzini, SE; Celius, E.G.; Elovaara, I et al. (2013). Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. (ekstern lenke)
• Beecham, Ashley H.; Patsopoulos, NA; Xifara, DK et al. (2013). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. (ekstern lenke)
• Ban, Maria; Caillier, Stacy; Mero, Inger-Lise et al. (2013). No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. (ekstern lenke)
• Kampman, Margitta Theodora; Aarseth, Jan Harald; Grytten, Nina Agnethe et al. (2013). Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway. (ekstern lenke)
• Rosella, Mechelli; Renato, Umeton; Policano, Claudia et al. (2013). A ‘‘candidate-interactome’’ aggregate analysis of genome-wide association data in multiple sclerosis. (ekstern lenke)
• Fjær, Sveinung; Bø, Lars; Lundervold, Arvid et al. (2013). Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model. (ekstern lenke)
• Løken-Amsrud, Kristin Ingeleiv; Myhr, Kjell-Morten; Bakke, Søren Jacob et al. (2013). Alpha-tocopherol and MRI outcomes in multiple sclerosis - association and prediction. (ekstern lenke)
• Holmøy, Trygve; Løken-Amsrud, Kristin Ingeleiv; Bakke, Jacob et al. (2013). Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity. (ekstern lenke)
• Grytten, Nina Agnethe; Torkildsen, Øivind; Aarseth, Jan Harald et al. (2013). Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. (ekstern lenke)
• Olsson, Tomas; Achiron, Anat; Alfredsson, Lars et al. (2013). Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort. (ekstern lenke)
• Myhr, Kjell-Morten; Grytten, Nina Agnethe; Aarseth, Jan Harald (2012). The Norwegian Multiple Sclerosis Registry and Biobank. (ekstern lenke)
• Torkildsen, Øivind; Grytten, Nina Agnethe; Aarseth, Jan Harald et al. (2012). Month of birth as a risk factor for multiple sclerosis: an update. (ekstern lenke)
• Pugliatti, M; Eskic, D.; Mikolcic, T et al. (2012). Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS. (ekstern lenke)
• Holmøy, Trygve; Torkildsen, Øivind; Myhr, Kjell-Morten et al. (2012). Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore. (ekstern lenke)
• Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten et al. (2012). The cuprizone model: regional heterogeneity of pathology. (ekstern lenke)
• Gavasso, Sonia; Torkildsen, Øivind; Marøy, Tove Helene et al. (2012). Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls. (ekstern lenke)
• Lunde, Hanne Marie; Aae, Tommy Frøseth; Indrevåg, William et al. (2012). Poor Sleep in Patients with Multiple Sclerosis. (ekstern lenke)
• Svendsen, Bjørn; Myhr, Kjell-Morten; Nyland, Harald Inge et al. (2012). The cost of multiple sclerosis in Norway. (ekstern lenke)
• Torkildsen, Øivind; Wergeland, Stig; Bakke, Jacob et al. (2012). ω-3 fatty acid treatment in multiple sclerosis (OFAMS study): a randomised, double blind, placebo-controlled trial. (ekstern lenke)
• Mero, Inger-Lise; SMESTAD, CATHRINE; Lie, Benedicte Alexandra et al. (2012). Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course. (ekstern lenke)
• Pugliatti, Maura; Casetta, Ilaria; Drulovic, Jelena et al. (2012). A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). (ekstern lenke)
• Kroksveen, Ann Cathrine; Guldbrandsen, Astrid; Vedeler, Christian A. et al. (2012). Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls. (ekstern lenke)
• Myhr, Kjell-Morten; Grytten, Nina Agnethe; Torkildsen, Øivind et al. (2012). A need for national registries and international collaborative research in multiple sclerosis. (ekstern lenke)
• Benth, Jurate Saltyte; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv et al. (2012). Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients. (ekstern lenke)
• Løken-Amsrud, Kristin Ingeleiv; Holmøy, Trygve; Bakke, Søren J. et al. (2012). Vitamin D and disease activity in multiple sclerosis before and during interferon beta treatment. (ekstern lenke)
• Gavasso, Sonia; Gjertsen, Bjørn Tore; Anderssen, Endre et al. (2012). Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis. (ekstern lenke)
• Glad, Solveig B; Nyland, Harald Inge; Aarseth, Jan Harald et al. (2011). How long can you keep working with benign multiple sclerosis?. (ekstern lenke)
• Mero, Inger-Lise; Ban, Maria; Lorentzen, Åslaug Rudjord et al. (2011). Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus. (ekstern lenke)
• Sawcer, S; Hellenthal, G; Pirinen, M et al. (2011). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. (ekstern lenke)
• Sørensen, Per Soelberg; Jensen, Poul Erik Hyldgaard; Haghikia, Aiden et al. (2011). Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. (ekstern lenke)
• Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten et al. (2011). Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. (ekstern lenke)
• Riise, Trond; Kirkeleit, Jorunn; Aarseth, Jan Harald et al. (2011). Risk of MS is not associated with exposure to crude oil, but increases with low level of education. (ekstern lenke)
• Smedal, Tori; Beiske, Antonie Giæver; Glad, Solveig Bergliot et al. (2011). Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance. (ekstern lenke)
• Søndergaard, Helle Bach; Sellebjerg, Finn; Hillert, Jan et al. (2011). Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655. (ekstern lenke)
• Smedal, Tori; Myhr, Kjell-Morten; Aarseth, Jan Harald et al. (2011). The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis. (ekstern lenke)
• Risberg, Geir; Aarseth, Jan Harald; Nyland, Harald Inge et al. (2011). Prevalence and incidence of multiple sclerosis in Oppland County – a cross-sectional population-based study in a landlocked county of Eastern Norway. (ekstern lenke)
• Glad, Solveig Bergliot; Aarseth, Jan Harald; Nyland, Harald Inge et al. (2010). Benign multiple sclerosis: a need for a consensus. (ekstern lenke)
• Smedal, Tori; Myhr, Kjell-Morten; Aarseth, Jan Harald et al. (2010). The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis. (ekstern lenke)
• Mero, Inger-Lise; Lorentzen, Åslaug Rudjord; SMESTAD, CATHRINE et al. (2010). A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. (ekstern lenke)
• Kvalheim, Tarja Anniki Rajalahti; Kroksveen, Ann Cathrine; Arneberg, Reidar et al. (2010). A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis. (ekstern lenke)
• Smedal, Tori; Johansen, Hilde Haukelid; Myhr, Kjell-Morten et al. (2010). Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS-29). (ekstern lenke)
• Lorentzen, Åslaug Rudjord; Melum, Espen; Ellinghaus, Eva et al. (2010). Association to the Glypican-5 gene in multiple sclerosis. (ekstern lenke)
• Næss, Halvor; Glad, Solveig B; Storstein, Anette et al. (2010). Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report. (ekstern lenke)
• Lode, Kirsten; Bru, Edvin; Klevan, Gry et al. (2010). Coping with multiple sclerosis: a 5-year follow-up study. (ekstern lenke)
• Næss, Halvor; Sundal, Endre; Myhr, Kjell-Morten et al. (2010). Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. (ekstern lenke)
• Harbo, Hanne Flinstad; Riccio, Maria Elena; Lorentzen, Åslaug Rudjord et al. (2010). Norwegian Sami differs significantly from other Norwegians according to their HLA profile. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Stansberg, Christine; Angelskår, Solveig Mjelstad et al. (2010). Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Brunborg, Linn Anne; Thorsen, Frits Alan et al. (2009). Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. (ekstern lenke)
• Comi, G; Martinelli, V; Rodegher, M et al. (2009). Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. (ekstern lenke)
• Sorensen, PS; Mellgren, SI; Svenningsson, A et al. (2009). NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. (ekstern lenke)
• Glad, Solveig Bergljot; Nyland, Harald Inge; Aarseth, Jan Harald et al. (2009). Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway. (ekstern lenke)
• Magitta, Ng'weina Francis; Wolff, Anette Susanne Bøe; Johansson, Stefan et al. (2009). A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. (ekstern lenke)
• Rajalahti, Tarja; Arneberg, Reidar; Kroksveen, Ann Cathrine et al. (2009). Discriminating Variable Test and Selectivity Ratio Plot: Quantitative Tools for Interpretation and Variable (Biomarker) Selection in Complex Spectral or Chromatographic Profiles. (ekstern lenke)
• Aarskog, Nina Karin; Marøy, Tove; Myhr, Kjell-Morten et al. (2009). Antibodies against interferon-beta in multiple sclerosis. (ekstern lenke)
• Lode, Kirsten; Bru, Edvin; Klevan, G. et al. (2009). Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Brunborg, Linn Anne; Milde, Anne Marita et al. (2009). A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination. (ekstern lenke)
• Rajalahti, Tarja; Arneberg, Reidar; Berven, Frode et al. (2009). Biomarker discovery in mass spectral profiles by means of selectivity ratio plot. (ekstern lenke)
• Lode, Kirsten; Bru, Edvin; Klevan, Gry et al. (2009). Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis. (ekstern lenke)
• Myhr, Kjell-Morten (2009). Vitamin D treatment in multiple sclerosis. (ekstern lenke)
• Sorensen, PS; Mellgren, Svein Ivar; Svenningsson, A et al. (2009). NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Knappskog, Per; Nyland, Harald Inge et al. (2008). Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. (ekstern lenke)
• Figved, N; Benedict, R; Klevan, G et al. (2008). Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis. (ekstern lenke)
• Dahl, J; Myhr, KM; Daltveit, Anne Kjersti Nesje et al. (2008). Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. (ekstern lenke)
• Grytten, Nina Agnethe; Lie, Stein Atle; Aarseth, Jan Harald et al. (2008). Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway. (ekstern lenke)
• Yu, Xinhua; Koczan, Dirk; Sulonen, Anna-Maija et al. (2008). mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis. (ekstern lenke)
• Næss, Halvor; Beiske, Antonie Giæver; Myhr, Kjell-Morten (2008). Quality of life among young patients with ischaemic stroke compared with patients with multiple sclerosis. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Nyland, Harald Inge; Myrmel, Helge et al. (2008). Epstein-Barr virus reactivation and multiple sclerosis. (ekstern lenke)
• Myhr, Kjell-Morten (2008). Diagnosis and treatment of multiple sclerosis. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Brunborg, Linn Anne Bjelland; Myhr, Kjell-Morten et al. (2008). The cuprizone model for demyelination. (ekstern lenke)
• Magitta, Ng’weina Francis; Bøe, AS; Johansson, S et al. (2008). A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. (ekstern lenke)
• Beiske, AG; Svensson, Elisabeth Karin; Sandanger, I et al. (2008). Depression and anxiety amongst multiple sclerosis patients. (ekstern lenke)
• Pugliatti, M.; Harbo, HF; Harbo, H.F. et al. (2008). Environmental risk factors in multiple sclerosis. (ekstern lenke)
• Lorentzen, Åslaug R; Smestad, Cathrine; Lie, Benedicte A et al. (2008). The SH2D2A gene and susceptibility to multiple sclerosis. (ekstern lenke)
• Figved, Nanna; Myhr, Kjell-Morten; Larsen, Jan Petter et al. (2007). Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms. (ekstern lenke)
• Lode, Kirsten; Larsen, J.P.; Bru, Edvin et al. (2007). Patient information and coping styles in multiple sclerosis. (ekstern lenke)
• Berven, Frode; Kroksveen, Ann Cathrine; Berle, Magnus Foldal et al. (2007). Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. (ekstern lenke)
• Beiske, AG; Naess, H; Aarseth, JH et al. (2007). Health-related quality of life in secondary progressive multiple sclerosis. (ekstern lenke)
• Harbo, HF; Utsi, E; Lorentzen, Åslaug Rudjord et al. (2007). Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami. (ekstern lenke)
• Arneberg, Reidar; Rajalahti, Tarja; Flikka, Kristian et al. (2007). Pretreatment of mass spectral profiles: Application to proteomic data. (ekstern lenke)
• Wolff, Anette Susanne Bøe; Myhr, Kjell-Morten; Vedeler, Christian A. et al. (2007). Fc gamma receptor polymorphisms are not associated with autoimmune Addison's disease. (ekstern lenke)
• Nortvedt, Monica; Riise, Trond; Frugård, Jannicke et al. (2007). Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. (ekstern lenke)
• Hensiek, Anke E.; Seaman, Shaun Robert; Barcellos, Lisa F. et al. (2007). Familial effects on the clinical course of multiple sclerosis. (ekstern lenke)
• Beiske, Antonie Giæver; Næss, Halvor; Aarseth, Jan Harald et al. (2007). Health-related quality of life in secondary progressive multiple sclerosis. (ekstern lenke)
• Lode, Kirsten; Larsen, Jan Petter; Bru, Edvin et al. (2007). Patient information and coping styles in multiple sclerosis. (ekstern lenke)
• Nortvedt, Monica W; Riise, Trond; Frugård, J et al. (2007). Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. (ekstern lenke)
• Datta, Pameli; Harbo, Hanne F; Ryder, Lars P. et al. (2007). A follow-up study of Nordic multiple sclerosis candidate gene regions. (ekstern lenke)
• Dahl, Julie; Myhr, Kjell-Morten; Daltveit, Anne Kjersti Nesje et al. (2007). Is smoking an extra hazard in pregnant MS women? Findings from a population-based registry in Norway. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Grytten, Nina Agnethe; Myhr, Kjell-Morten (2007). Immunomodulatory treatment of multiple sclerosis in Norway. (ekstern lenke)
• Myhr, Kjell-Morten (2006). Multippel sklerose. (ekstern lenke)
• Dahl, Julie; Myhr, Kjell-morten; Daltveit, Anne Kjersti Nesje et al. (2006). Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. (ekstern lenke)
• Dahl, Julie; Myhr, Kjell-Morten; Daltveit, Anne Kjersti et al. (2006). Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. (ekstern lenke)
• Beiske, AG; Naess, H; Aarseth, JH et al. (2006). Health-related quality of life in secondary progressive multiple sclerosis. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Vedeler, Christian A.; Nyland, Harald Inge et al. (2006). Fc gamma R and multiple sclerosis: an overview. (ekstern lenke)
• Gavasso, Sonia; Myhr, Kjell-Morten; Vedeler, Christian A. (2006). Multiplexed phosphoprotein analysis in immune cells. (ekstern lenke)
• Myhr, Kjell-Morten; Grytten, Nina; Aarseth, Jan Harald et al. (2006). The Norwegian Multiple Sclerosis National Competence Centre and National Multiple Sclerosis Registry - a resource for clinical practice and research. (ekstern lenke)
• Glad, Solveig; Nyland, Harald Inge; Myhr, Kjell-Morten (2006). Benign multiple sclerosis. (ekstern lenke)
• Smedal, Tori; Lygren, Hildegunn; Myhr, Kjell-Morten et al. (2006). Balance and gait improved in patients with MS after physiotherapy based on the Bobath concept. (ekstern lenke)
• Næss, Halvor; Waje-Andreassen, Ulrike; Thomassen, Lars et al. (2006). Health-related quality of life among young adults with ischemic stroke on long-term follow-up. (ekstern lenke)
• Grytten, Nina Agnethe; Glad, Solveig B.; Aarseth, Jan Harald et al. (2006). A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. (ekstern lenke)
• Torkildsen, Øyvind; Utsi, Egil; Harbo, Hanne F. et al. (2005). Ethnic Variations of IL-10 Polymorphisms in a Sami and Norwegian Population. (ekstern lenke)
• Torkildsen, Øyvind; Utsi, Egil; Mellgren, Svein Ivar et al. (2005). Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. (ekstern lenke)
• Lorentzen, Åslaug Rudjord; Celius, Elisabeth Gulowsen; Ekstrøm, Per Olaf et al. (2005). Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. (ekstern lenke)
• Torkildsen, O; Torkildsen, Øivind Fredvik; Utsi, Egil et al. (2005). Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population. (ekstern lenke)
• Figved, Nanna; Klevan, Gry; Myhr, Kjell-Morten et al. (2005). Neuropsychiatric symptoms in patients with multiple sclerosis. (ekstern lenke)
• Torkildsen, Øivind Fredvik; Vedeler, Christian A.; Ulvestad, Elling et al. (2005). High dose methylprednisolone induces FcgammaR1 on granulocytes in MS-patients. (ekstern lenke)
• Torkildsen, O; Torkildsen, Øivind Fredvik; Utsi, Egil et al. (2005). Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. (ekstern lenke)
• Gavasso, Sonia; Nygård, Ottar; Pedersen, Eva Kristine Ringdal et al. (2005). Fc gamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. (ekstern lenke)
• Dahl, Julie; Myhr, Kjell-Morten; Daltveit, Anne Kjersti et al. (2005). Pregnancy, delivery, and birth outcome in women with multiple sclerosis. (ekstern lenke)
• Næss, Halvor; Nyland, Harald Inge; Thomassen, Lars et al. (2005). Mild depression in young adults with cerebral infarction at long-term follow-up: A population-based study. (ekstern lenke)
• Næss, Halvor; Nyland, Harald Inge; Thomassen, Lars et al. (2005). Fatigue at long-term follow-up in young adults with cerebral infarction. (ekstern lenke)
• Næss, Halvor; Waje-Andreassen, Ulrike; Thomassen, Lars et al. (2005). Do all young ischemic stroke patients need long-term secondary preventive medication?. (ekstern lenke)
• Harbo, HF; Lie, BA; Sawcer, S et al. (2004). Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. (ekstern lenke)
• Naess, H; Nyland, Harald Inge; Thomassen, L et al. (2004). Long-term outcome of cerebral infarction in young adults. (ekstern lenke)
• Andersen, O; Elovaara, I; Farkkila, M et al. (2004). Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis. (ekstern lenke)
• Oturai, AB; Ryder, LP; Fredrikson, S et al. (2004). Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs. (ekstern lenke)
• Naess, H; Nyland, Harald Inge; Thomassen, L et al. (2004). Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population-based case-control study. (ekstern lenke)
• Nortvedt, Monica W; Riise, Trond; Myhr, Kjell-Morten et al. (2001). Quality of life as a predictor for change in disability in MS reply (letter). (ekstern lenke)
• Myhr, Kjell-Morten; Riise, Trond; Vedeler, C et al. (2001). Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. (ekstern lenke)
• Nortvedt, Monica W; Riise, Trond; Myhr, Kjell-Morten et al. (2001). Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (2000). Quality of life as a predictor for change in disability in multiple sclerosis. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (2000). Performens of the SF-36, SF-12 and RAND-36 summary scales in a multiple sclerosis population. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (1999). Quality of life in multiple sclerosis: Measuring the disease effects more broadly. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (1999). Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a. (ekstern lenke)

Leserinnlegg

• Torkildsen, Øivind; Myhr, Kjell-Morten; Brügger-Synnes, Pascal et al. (2024). Antiviral therapy with tenofovir in MS. (ekstern lenke)
• Lie, Ingrid Anne; Rød, Brit Ellen; Stokke, Silje Agnethe et al. (2023). Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis. (ekstern lenke)
• Nygaard, Gro Owren; Torgauten, Hilde Marie; Skattebøl, Lars et al. (2022). Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis. (ekstern lenke)
• Grytten, Nina; Torkildsen, Øivind; Myhr, Kjell-Morten (2015). Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'. (ekstern lenke)
• Torkildsen, Øivind; Aarseth, Jan Harald; Celius, Elisabeth Gulowsen et al. (2014). Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments. (ekstern lenke)
• Holmøy, Trygve; Løken-Amsrud, Kristin Ingeleiv; Kampman, Margitta Theodora et al. (2014). Re: Vitamin D-how much is enough, and is more better for your Health?. (ekstern lenke)
• Holmøy, Trygve; Myhr, Kjell-Morten; Bø, Lars (2014). Re: Uetisk av nevrologene ikke å tilby pasienter med multippel sklerose cytostatikabehandling med autolog stamcellestøtte. (ekstern lenke)
• Ramagopalan, Sreeram V; Hanwell, Heather EC; Giovannoni, Gavin et al. (2010). Vitamin D-Dependent Rickets, HIA-DRB1, and the Risk of Multiple Sclerosis. (ekstern lenke)
• Myhr, Kjell-Morten (2010). K.-M. Myhr svarer. (ekstern lenke)
• Beiske, Antonie Giæver; Myhr, Kjell-Morten (2006). Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis. (ekstern lenke)
• Waje-Andreassen, U; Kråkenes, Jostein; Ulvestad, Elling et al. (2005). Response to: Interleukin-6 and acute ischaemic stroke. (ekstern lenke)

Poster

• Gavasso, Sonia; Haugsøen, Jonas Bull; Kleftogiannis, Dimitrios et al. (2024). Short-Term and Long-Term Impact of Autologous Haematopoietic Stem Cell Transplantation on Immune Profiles in Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• König, Marton; Wolf, Asia-Sophia Fumika Michaela; Ravussin, Anthony et al. (2022). Immunogenicity and efficacy of mRNA-COVID-19 vaccines in people with multiple sclerosis. (ekstern lenke)
• Serkland, Trond Trætteberg; Hallin, Erik Ingmar; Myhr, Kjell-Morten et al. (2022). LC-MS/MS quantification of ocrelizumab in the treatment of multiple sclerosis. (ekstern lenke)
• König, Marton; Lorentzen, Åslaug Rudjord; Torgauten, Hilde Marie et al. (2021). Humoral Immunity to SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis using High-Efficacy Disease Modifying Therapies. (ekstern lenke)
• Myhr, Kjell-Morten; Schuler, Stephan; Alstadhaug, Karl Bjørnar (2019). Long-term, real-world effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis (RRMS): data from ≥6 years in the TYSABRI® Observational Program (TOP) Nordic and global cohorts.. (ekstern lenke)
• Bhan, Alok; Jacobsen, Cecilie Osman; Lode, Kirsten et al. (2016). Neurofilament light chain and disease progression in MS. (ekstern lenke)
• Wesnes, Kristin; Riise, Trond; Myhr, Kjell-Morten et al. (2012). The relationship between body size and the risk of multiple sclerosis. -The EnvIMS study. (ekstern lenke)
• Myhr, Kjell-Morten; Marøy, Tove Helene; Gavasso, Sonia et al. (2007). Nøytraliserende antistoffer mot interferon-beta ved Multippel Sclerose. (ekstern lenke)
• Gavasso, Sonia; Aarskog, Nina Karin; Myhr, Kjell-Morten et al. (2004). Fc gamma receptor expression of peripheral leukocytes in Multiple Sclerosis patients treated with interferon-beta or glatiramer acetate.. (ekstern lenke)
• Riise, Trond; Myhr, Kjell-Morten; Casetta, Ilaria et al. (2004). A multicentric case-control study on multiple sclerosis. (ekstern lenke)
• Nyland, Harald; Nortvedt, Monica W; Myhr, Kjell-Morten et al. (2003). Pasienter med benign multippel sklerose har redusert helserelatert livskvalitet. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (2000). Livskvalitet og multippel sklerose. Betydningen av subjektive og objektive sykdomstegn for livskvaliteten til mennesker med multippel sklerose. (ekstern lenke)
• Myhr, Kjell-Morten; Riise, Trond; Lillås, F et al. (2000). Result from design of a randomised, placebo-controlled, double blind trial in Norway. Treatment of relapsing-remittent multiple sclerosis with recombinant human interferon-alfa-2a. (ekstern lenke)
• Myhr, Kjell-Morten; Riise, Trond; Vedeler, Christian A et al. (2000). Long-term prognosis in a incidence cohort of 219 multiple sclerosis patients from Hordaland county, Western Norway. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (2000). Perfomance of the SF-12 Health Survey in a population of multiple sclerosis patients. (ekstern lenke)

Fagartikkel

• Skoie, Inger Marie; Skogås, Jan Gunnar; Langø, Thomas et al. (2023). Nye sentre skal gi flere kliniske studier i Norge. (ekstern lenke)
• Torkildsen, Øivind; Holmøy, Trygve; Myhr, Kjell-Morten (2018). Severe multiple sclerosis reactivation after gonadotropin treatment. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (1995). Forskning på livskvalitet, multippel sklerose. (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Lie, Ingrid Anne; Weeda, Merlin M.; Mattiesing, Rozemarijn M. et al. (2022). Relationship between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis. (ekstern lenke)
• Holmøy, Trygve; Høglund, Rune Alexander; Illes, Zsolt et al. (2020). Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder. (ekstern lenke)
• Vermersch, Patrick; Oh, Jiwon; Cascione, Mark et al. (2020). Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS. (ekstern lenke)
• Myhr, Kjell-Morten; Torkildsen, Øivind; Lossius, Peter Andreas Vold et al. (2019). B cell depletion in the treatment of multiple sclerosis. (ekstern lenke)
• Varhaug, Kristin Nielsen; Torkildsen, Øivind; Myhr, Kjell-Morten et al. (2019). Neurofilament light chain as a biomarker in multiple sclerosis. (ekstern lenke)
• Alstadhaug, Karl Bjørnar; Myhr, Kjell-Morten; Rinaldo, Christine Hanssen (2017). Progredierende multifokal leukoencefalopati. (ekstern lenke)
• Fazekas, Franz; Gehring, Klaus; Gallo, Paolo et al. (2015). Country break-out session highlights. (ekstern lenke)
• Myhr, Kjell-Morten; Grytten, Nina; Torkildsen, Øivind et al. (2015). The Norwegian Multiple Sclerosis Registry and Biobank. (ekstern lenke)
• Grytten, Nina; Torkildsen, Øivind; Myhr, Kjell-Morten (2015). Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. (ekstern lenke)
• Gnanapavan, Sharmilee; Hegen, Harald; Khalil, Marwan et al. (2014). Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. (ekstern lenke)
• Flachenecker, Peter; Buckow, Karoline; Pugliatti, Maura et al. (2014). Multiple sclerosis registries in Europe - Results of a systematic survey. (ekstern lenke)
• Lunde, Hanne Marie; Bjorvatn, Bjørn; Myhr, Kjell-Morten et al. (2013). Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review. (ekstern lenke)
• Stokke, Silje Agnethe; Wergeland, Stig; Torkildsen, Øivind et al. (2013). Neuromyelitis optica. (ekstern lenke)
• Wergeland, Stig; Torkildsen, Øivind; Bø, Lars et al. (2012). Polyunsaturated fatty acids in multiple sclerosis therapy. (ekstern lenke)
• Myhr, K M; Mellgren, Svein Ivar (2009). Corticosteroids in the treatment of multiple sclerosis. (ekstern lenke)
• Midgard, R; Beiske, AG; Celius, EG et al. (2003). New diagnostic criteria in multiple sclerosis. (ekstern lenke)

Kronikk

• Torkildsen, Øivind; Rød, Brit Ellen; Bø, Lars et al. (2022). Amming og behandling av multippel sklerose. (ekstern lenke)
• Glover, Joel; Tysnes, Ole-Bjørn; Myhr, Kjell-Morten et al. (2019). Hvor står ALS-forskningen i Norge?. (ekstern lenke)

Vitenskapelig foredrag

• Serkland, Trond Trætteberg; Hallin, Erik Ingmar; Myhr, Kjell-Morten et al. (2022). Rituximab in the treatment of multiple sclerosis: A pharmacokinetic-pharmacodynamic model. (ekstern lenke)
• Cortese, Marianna; Riise, Trond; Bjørnevik, Kjetil Lauvland et al. (2015). Evidence of preclinical disease activity­ a prospective study on cognitive and physical performance prior to first symptom of multiple sclerosis. (ekstern lenke)
• Røsjø, Egil Rørvik; Myhr, Kjell-Morten; Kampman, Margitta Theodora et al. (2015). Vitamin D og interferon-behandling ved multippel sklerose. (ekstern lenke)
• Bjørnevik, Kjetil Lauvland; Riise, Trond; Kirkeleit, Jorunn et al. (2014). Level of education and multiple sclerosis risk after adjustment for known risk factors: the EnvIMS study. (ekstern lenke)
• Rajalahti, Tarja; Arneberg, Reidar; Flikka, Kristian et al. (2007). Preteatment of Mass Spectral Profiles: Application to proteomic data. (ekstern lenke)
• Kvalheim, Olav Martin; Rajalahti, Tarja; Arneberg, Reidar et al. (2007). Analysis of Proteomic Profiles. (ekstern lenke)
• Kvalheim, Olav Martin; Rajalahti, Tarja; Arneberg, Reidar et al. (2007). Target projection and proper data pre-treatment for the analysis of proteomic profiles. (ekstern lenke)
• Svendsen, Bjørn; Myhr, Kjell-Morten; Nyland, Harald et al. (2006). Costs and quality of life in patients with multiple sclerosis in Norway compared to 9 other European countries. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (2000). Livskvalitet hos multippel sklerose pasienter - en utfordring for sykepleien. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (2000). Livskvalitet hos multippel sklerose pasienter. (ekstern lenke)
• Riise, Trond; Nortvedt, Monica Wammen; Myhr, Kjell-Morten et al. (2000). Quality of life as a predictor for change in disability in multiple sclerosis. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (2000). Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (1999). Expanded Disability Status Scale scores and the Quality of Life of Multiple Sclerosis patients. An epidemiological study. (ekstern lenke)
• Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten et al. (1999). The quality of life of multiple sclerosis patients in a treatment trial with recombinant interferon-alfa-2a. (ekstern lenke)
• Riise, Trond; Nortvedt, Monica Wammen; Myhr, Kjell-Morten et al. (1999). Lack of agreement between objective disease measures and the Quality of Life in a treatment trial in multiple sclerosis. (ekstern lenke)

Doktorgradsavhandling

• Cortese, Marianna; Myhr, Kjell-Morten (2017). The timing of environmental risk factors and prodromal signs of multiple sclerosis. (ekstern lenke)
• Fjær, Sveinung; Myhr, Kjell-Morten (2016). Magnetization Transfer Ratio in Experimental Models of Multiple Sclerosis. (ekstern lenke)
• Torkildsen, Nina A. Grytten; Nyland, Harald Inge; Myhr, Kjell-Morten et al. (2008). Multiple Sclerosis in Western Norway. Incidence, prevalence, survival and ‘the lived experience'. (ekstern lenke)

Vitenskapelig Kapittel/Artikkel/Konferanseartikkel

• Myhr, Kjell-Morten (2015). Neuromyelitis Optica. (ekstern lenke)
• Myhr, Kjell-Morten (2015). Multiple Sclerosis. (ekstern lenke)
• Myhr, Kjell-Morten; Torkildsen, Øivind; Bø, Lars (2014). Multippel Sklerose. (ekstern lenke)
• Myhr, Kjell-Morten; Nyland, Harald Inge (2007). Multippel sklerose. (ekstern lenke)

Rapport

• Svendsen, Bjørn; Aarseth, Jan Harald; Nyland, Harald et al. (2007). Økonomisk analyse av behandling av MS-pasienter med Tysabri® i Norge. (ekstern lenke)
• Svendsen, Bjørn; Myhr, Kjell-Morten; Nyland, Harald et al. (2006). The cost of multiple sclerosis in Norway ? (and how certain can we be?). (ekstern lenke)

Populærvitenskapelig artikkel

• Myhr, Kjell-Morten (2005). Har omega-3 noen effekt på MS?. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin